The proportion of lung cancer survivors is growing worldwide ([@bib11]) and in Taiwan ([@bib21]). Patients with lung cancer frequently experience psychological problems, such as anxiety and depression. The prevalence rates of anxiety and depression in lung cancer survivors are 34% and 33%, respectively ([@bib13]). Lung cancer is a highly symptomatic disease, involving symptoms such as pain, fatigue, sleep disturbance, shortness of breath and dry mouth during the treatment period and in the follow-up stage ([@bib28]; [@bib24]). Anxiety, depression and cancer-related symptoms might limit the functional ability and impair the quality of life (QOL) in lung cancer survivors.

Although exercise provides several benefits for patients with cancer, the effects of exercise on anxiety, depression and cancer-related symptoms have been inconsistently reported in various studies. As demonstrated by three previous studies, exercise can reduce both anxiety and depression ([@bib19]), only anxiety ([@bib2]), or only depression ([@bib20]) in patients with breast cancer and other cancers. However, four previous studies have indicated that exercise intervention is ineffective in reducing both anxiety and depression in the patient population with breast, lung, colorectal and other cancers ([@bib27]; [@bib8]; [@bib14]; [@bib17]). Regarding cancer-related symptoms, a study with a small sample size demonstrated that exercise can reduce the symptoms of advanced lung cancer such as coughing and dyspnoea ([@bib27]). Conversely, two other studies have indicated that exercise has no effect on cancer-related symptoms such as fatigue and sleep disturbance in patients with breast, colorectal or ovarian cancer ([@bib7]; [@bib17]). These studies have involved the use of various exercise modalities (e.g., brisk walking, running, cycling, swimming and resistance training), including various exercise modes with varying frequency, intensity and duration, thereby resulting in inconsistent conclusions.

[@bib26] suggested that patients with cancer must perform moderate-intensity aerobic exercises such as walking and cycling for 20--60 min per session for 3--5 days per week to improve mood and QOL and reduce fatigue ([@bib26]). Walking is strongly recommended for patients with pulmonary diseases because it is involved in most activities of daily living (ADLs) ([@bib1]). In addition, walking is the most preferred exercise of patients with lung cancer because it is flexible and can be performed alone in Taiwanese patients with lung cancer ([@bib18]).

A home-based, moderate-intensity walking programme can reduce anxiety ([@bib22]; [@bib6]), depression ([@bib6]) and the severity of cancer-related symptoms ([@bib22]; [@bib6]; [@bib23]; [@bib5]) in patients with breast and colorectal cancers; however, research on the effects of home-based walking exercise on patients with lung cancer remains limited. The current study aimed to determine the effectiveness of a 12-week home-based walking-exercise programme in managing anxiety, depression and the severity of cancer-related symptoms in Taiwanese patients with lung cancer. We hypothesised the walking-exercise group to be superior to the usual-care group regarding patient-rated anxiety, depression and the severity of cancer-related symptoms. According to a thorough literature review, this is the first study that investigates the psychological effects of home-based walking exercise on patients with lung cancer.

Materials and Methods
=====================

Research design and study sample
--------------------------------

We conducted a parallel, randomised, controlled and single-centre trial with a home-based walking-exercise group and a usual-care group. Participants were recruited from a medical centre in northern Taiwan with the following eligibility criteria: patients who were diagnosed with primary lung cancer, were aged ⩾18 years, were able to speak Mandarin or Taiwanese and who exhibited no cognitive impairment. A patient was excluded if he or she (1) had engaged in regular exercise (150 min per week, moderate intensity) or had received cognitive behaviour therapy in the past 6 months; (2) had been diagnosed with congestive heart disease; (3) had been diagnosed with lower limb orthopaedic diseases that restrict walking ability; or (4) had been diagnosed with repeated onset of depression. The study protocol was approved by the Institutional Review Board of Taipei Veterans General Hospital (Taipei, Taiwan).

Procedure
---------

When the patients visited a physician at the outpatient department of this hospital and agreed to participate in the study, they were referred to the researcher, who explained the study procedure. After the participants received an explanation and provided informed consent, they underwent a baseline assessment (T1) at the hospital. The researchers used a computer to generate a randomisation list featuring four-person blocks before performing the experiments; the lists of the various groups were then sealed inside opaque envelops. During pretest data collection, one of the researchers opened the envelopes and randomly assigned participants to the walking-exercise or the usual-care group. Follow-up questionnaires were distributed by post during the third (T2) and sixth (T3) months. On study completion, the usual-care group participants received a walking-exercise booklet by post.

Intervention
------------

The exercise programme was a 12-week home-based, moderate-intensity walking-exercise programme consisting of 40 min per session, 3 sessions per week, and weekly exercise counselling. During the enrolment period, we offered a walking-exercise booklet to the participants, and used its contents to instruct the patients regarding the mode, intensity and frequency of exercise; pulse-rate measurement; Borg\'s rating of perceived exertion (RPE) scale (6--20) ([@bib3]); prevention of sports injuries; and the time point of terminating the exercise. Each participant was instructed to achieve a target heart rate of 60--80%, based on the Karvonen method ([@bib15]), and a score of 13--15 on the RPE scale. In addition, the aforementioned researcher conducted weekly telephone interviews with the participants to discuss their exercise experiences and remind them to complete the exercise records. When a participant had not exercised for a minimum of 3 days because of reasons other than physical illness, the exercise programme content was reviewed with the participant, and he or she was encouraged to continue exercising. Because we contacted the participants to teach them the walking exercise, and also collected data during the follow-up periods, blinding of both the patients and the researcher was impossible. To compensate, three data (T1, T2 and T3) key-in procedures were performed by a research assistant to obscure patient identification data (e.g., names) before submitting the data to the researchers for subsequent statistical analyses. In addition, to control the research quality, the progress of this study was reported annually to the Institutional Review Board of Taipei Veterans General Hospital (Taipei, Taiwan). Project aspects, such as research design and intervention measures, were not modified during the research period.

Study measures
--------------

The patients\' demographic data, including age, sex, educational attainment, employment status and marital status, were obtained using a baseline questionnaire. The cancer stage and current treatment records were acquired from the baseline medical records of the patients. The primary outcomes were anxiety and depression, as assessed using the Hospital Anxiety and Depression Scale (HADS) ([@bib29]), that comprises seven items each for anxiety and depression. Each item of the anxiety subscale (HADS-A) and the depression subscale (HADS-D) was scored on a 4-point scale from 0 (not at all) to 3 (very much so). Higher scores indicated higher anxiety or depression levels. Subscale scores of ⩾11 were considered to indicate a 'definite case\', whereas subscale scores of 8 to 10 and 0 to 7 were considered to be a 'suspicious case\' and a 'noncase\', respectively, of anxiety or depression ([@bib29]). This scale is a reliable tool, and is widely used to assess patients with cancer ([@bib10]; [@bib8]). We anticipated that the effects of exercise on anxiety and depression would be observable during the third month (T2) after intervention.

The secondary outcomes comprised the severity of cancer-related symptoms including pain, fatigue, nausea, sleep disturbance, sadness, shortness of breath, difficulty remembering, poor appetite, drowsiness, dry mouth, distress, vomiting and numbness that were assessed using the Taiwanese version of the MD Anderson Symptom Inventory (MDASI-T) ([@bib16]). MDASI-T comprises 13 single-item measures of symptom intensity in the past 24 h, each of which is scored on an 11-point scale from 0 (not at all) to 10 (as bad as you can imagine). The symptom severity score was an average of these 13 symptom items: higher scores indicated greater symptom intensity. The questionnaire was validated for a sample of Taiwanese patients with cancer, which exhibited a strong Cronbach\'s *α*, with an internal consistency of 0.89 and a test--retest reliability of 0.97 ([@bib16]). The MDASI-T scale is a reliable tool and has been used to assess Taiwanese patients with cancer ([@bib4]; [@bib24]).

Statistical analysis and sample size calculation
------------------------------------------------

Based on the results from the eight participants in the pilot study, the mean (±s.d.) HADS-A scores of the walking-exercise and usual-care groups were 3.50 (3.42) and 5.75 (3.78), respectively, after the 12-week home-based walking exercise programme. Using the G\*Power software (version 3.1.0) ([@bib9]) for repeated measures, and with a significance level of 0.05, an effect size of 0.30, a power of 0.8 and a correlation of 0.8, the sample size was estimated as 40 patients for each group. Based on an assumed dropout rate of 30%, 104 patients were considered adequate.

We used an intention-to-treat (ITT) approach. All statistical analyses were conducted using the IBM Statistical Package for the Social Sciences (SPSS) (Version 20) for Windows (IBM, Somers, NY, USA). We used *t-*test or *χ*^2^-test to determine the differences in the demographic data and the disease characteristics or outcome variables at baseline between the non-dropout patients (measured at all three time points) and the dropout patients (measured at one or two time points only). We used descriptive statistics to analyse the demographic data and disease characteristics as well as anxiety, depression and cancer-related symptom severity. We compared the baseline values for the demographic data, disease characteristics and outcome measures between the walking-exercise and usual-care groups by using the *t-*test or the *χ*^2^-test.

We used a general linear model to evaluate the mean and s.d. values, and the differences between the group outcomes (anxiety, depression and cancer-related symptom severity) at the baseline, third month and sixth month, and to model the outcomes (anxiety, depression and cancer-related symptom severity) as a function of the main effect (group differences) and main time effect. Both stability and repeated relationship analyses were conducted using generalised estimation equations (GEE). We added an interaction term (group difference × time) to each model to investigate the cooperative effect of exercise and time. The changes in study outcome values (anxiety, depression and cancer-related symptom severity) from baseline to follow-up periods (third and sixth months) were expressed in both the walking-exercise and usual-care groups. We used the general linear model to model the outcomes (number of patients with anxiety and depression according to the clinical cutoff point) as a function of the main effect (group differences). Both stability and repeated relationship analyses were conducted using GEE. An interaction term (group difference × time) was added to each model to investigate the interactive effects of exercise and time. All the tests involved a two-sided significance level of *α*=0.05.

Trial Registry: [www.chictr.org](http://www.chictr.org); Identifier: ChiCTR-TRC-14004756.

Results
=======

Participant characteristics
---------------------------

Participants were recruited from March 2010 to November 2012. As shown in [Figure 1](#fig1){ref-type="fig"}, 120 eligible patients from the outpatient department were referred by two physicians for study enrolment. After face-to-face consultations during which the study protocols and aims were explained to the patients in the hospital, four patients were excluded because they were uninterested or too busy to participate. As shown in [Table 1](#tbl1){ref-type="table"}, the sample comprised 116 patients (54 men and 62 women) aged 37--88 years, with a mean age of 64.16±10.89 years. Most participants were married and unemployed; 65% of participants had stage 1 lung cancer, and 54% had undergone operations. No statistically significant differences emerged in the baseline demographic data and disease characteristics between the walking and the usual-care groups (*P*\>0.050). In addition, no significant differences emerged in the amount of baseline physical activity between both groups.

Missing value analysis
----------------------

Measurements were recorded at 3 time points: the measurements for 91 (78.4%) participants (non-dropout patients) were recorded at all 3 time points, but for 25 participants (dropout patients), the measurements were recorded at 1 or 2 time points only, after which the patients dropped out. The dropout patients were older (68.14 *vs* 62.90 years, *P*=0.026) and exhibited higher baseline depression scores (6.57 *vs* 4.77, *P*=0.023) than did the non-dropout patients.

Overall, 14 (24.1%) and 11 (19.0%) participants dropped out in the walking and usual-care groups, respectively, but the difference that was observed in the dropout rates between the two groups (*x*^2^=0.450, *P*=0.498) was nonsignificant. The total attrition rate was 21.6%, and the reasons for dropping out are presented in [Figure 1](#fig1){ref-type="fig"}.

Protocol adherence
------------------

Of the 58 patients in the walking-exercise group, 26 (44.8%) completed the 12-week programme, and 36 (62%) completed at least half of the 12-week programme. The mean value of the number of completed walking-exercise sessions was 21.48 (s.d.=15.80). The exercise adherence rate was 59.7%. The participants did not complete the entire session because they either dropped out (*n*=10), perceived discomfort (*n*=12), lacked motivation (*n*=6) or were too busy (*n*=4). No exercise-related adverse effects were observed in the walking-exercise group during the study period.

Intervention effects on anxiety, depression and cancer-related symptoms
-----------------------------------------------------------------------

The mean anxiety scores at baseline were 4.59 (s.d.=3.46) and 3.50 (s.d.=3.91) in the walking-exercise and usual-care groups, respectively; no significant intergroup differences were observed (*t*=1.47, *P*=0.144; [Table 2](#tbl2){ref-type="table"}). The mean anxiety score of the walking-exercise group declined by 1.04 points between the baseline and the sixth month and was compared using the general linear model; however, this change was not statistically significant. In contrast, the mean anxiety score of the usual-care group at the third month (mean difference=1.72, *P*=0.012) increased significantly from baseline, and then remained stable until the sixth month ([Table 2](#tbl2){ref-type="table"}). The anxiety scores of the walking-exercise group declined by 0.63 points at the third month and by 1.03 points at the sixth month compared with the corresponding scores of the usual-care group, although these differences were not statistically significant ([Table 2](#tbl2){ref-type="table"}). Furthermore, a significant interaction term (group difference × time) of the model at the third month (*β*=−1.80, *P*=0.009) and sixth month (*β*=−2.18, *P*=0.006) verified that the walking exercise programme effectively reduced anxiety levels over time ([Table 3](#tbl3){ref-type="table"} and [Figure 2](#fig2){ref-type="fig"}).

The mean depression scores at baseline were 5.67 (s.d.=3.57) and 4.74 (s.d.=3.73) in the walking-exercise and usual-care groups, respectively. No significant intergroup differences were observed (*t*=1.37, *P*=0.173). The mean depression scores of the walking-exercise group gradually declined from baseline to the third and sixth months ([Table 2](#tbl2){ref-type="table"}), although these changes revealed no statistical significance in these scores. However, the mean depression scores of the usual-care group at the third month increased significantly from baseline (mean difference=2.63, *P*=0.0004), revealing a marginally significant increase at sixth month from baseline (mean difference=1.35, *P*=0.071; [Table 2](#tbl2){ref-type="table"}). In addition, significant differences were observed at the third and sixth months between the walking and the usual-care groups (mean difference=−2.45, *P*=0.001; mean difference=−1.68, *P*=0.035, respectively; [Table 2](#tbl2){ref-type="table"}). Furthermore, a significant interaction term (group difference × time) of the model at the third (*β*=−3.31, *P*=0.00006) and sixth (*β*=−2.57, *P*=0.004) months revealed that the participants engaging in walking exhibited further reductions in depression over time. These results indicated that the walking-exercise programme effectively reduced depression ([Table 3](#tbl3){ref-type="table"} and [Figure 3](#fig3){ref-type="fig"}).

At baseline, the mean symptom scores were 1.93 (s.d.=1.45) and 2.04 (s.d.=1.48) for the walking-exercise and usual-care groups, respectively. Because the value of presentation was skewed, the median and interquartile ranges (IQRs) were considered instead of the mean and s.d. values. The median symptom scores were 1.62 (IQR=0.90--3.10) and 2.11 (IQR=0.83--2.92) for the walking-exercise and the usual-care groups, respectively. No significant intergroup differences were observed (*t*=−0.41, *P*=0.683). Moreover, the mean symptom score of the walking-exercise group declined from the baseline to the third month (mean difference=0.43, *P*=0.137) and remained stable from the third to the sixth month (mean difference=0.04, *P*=0.896). However, the mean symptom scores of the usual-care group at the third (mean difference=0.04, *P*=0.886) and sixth (mean difference=0.30, *P*=0.313) months remained unaltered from the baseline ([Table 2](#tbl2){ref-type="table"}). A marginally significant difference was observed between both the groups at the third month (1.50 *vs* 2.08 points, *P*=0.053; [Table 2](#tbl2){ref-type="table"}). However, the model of the interaction term (group difference × time) at the third month was marginally significant (*β*=−0.43, *P*=0.050) but did not achieve statistical significance at the sixth month (*β*=−0.03, *P*=0.910) ([Table 3](#tbl3){ref-type="table"} and [Figure 4](#fig4){ref-type="fig"}). Detailed information is presented in [Tables 2](#tbl2){ref-type="table"} and [3](#tbl3){ref-type="table"}.

Intervention effects on anxiety and depression according to the clinical cutoff point
-------------------------------------------------------------------------------------

A cutoff point of 8 was used to investigate the clinical significance of the observed changes; the walking-exercise and usual-care groups revealed similar numbers of definite and suspicious (scores ⩾8) anxiety cases at baseline (13 *vs* 8, *P*=0.288). Although a significant difference was observed from the baseline to the third month (a decrease of 4 patients in the walking-exercise group *vs* an increase of 9 patients in the usual-care group, *P*=0.014), no significant differences were observed from the baseline to the sixth month (a decrease of 8 patients in the walking-exercise group *vs* no decrease in the usual-care group, *P*=0.118). A significant interaction term (group difference × time) in the GEE model (Wald *x*^2^=6.04, *P*=0.049) verified that the walking-exercise programme effectively reduced the number of patients with anxiety over time ([Table 4](#tbl4){ref-type="table"}).

Similarly, when the cutoff point of 8 was used to investigate the clinical relevance of the observed changes, both the walking-exercise and usual-care groups revealed a similar number of definite and suspicious (scores ⩾8) depression cases at baseline (18 *vs* 14, *P*=0.406). Moreover, although a significant difference was observed from the baseline to the third month (a decrease of 8 patients *vs* an increase of 9 patients, *P*=0.001), no significant differences were observed from the baseline to the sixth month (a decrease of 5 patients *vs* an increase of 2 patients, *P*=0.257). The significant interaction term (group difference × time) in the GEE model (Wald *x*^2^=10.74, *P*=0.005) indicated that the walking-exercise programme effectively reduced the number of patients with depression over time ([Table 4](#tbl4){ref-type="table"}).

Discussion
==========

This is the first study to investigate the psychological effects of a home-based walking-exercise programme on patients with lung cancer. The trial results support the hypothesis that a home-based walking exercise exerts positive effects on anxiety and depression in patients with lung cancer. These results are consistent with those obtained in previous studies on patients with colorectal and breast cancer ([@bib22]; [@bib6]; [@bib19]). In addition, our results indicate that the psychological benefits of exercise observed in other cancer populations apply to patients with lung cancer as well. However, a previous study ([@bib8]) conducted a 12-week, home-based, self-directed exercise programme (e.g., swimming and running) for patients with breast cancer and reported negative results; this may have been caused by 36% lower exercise adherence rates. Similarly, another study ([@bib14]) adopted a home-based walking exercise programme that included a 12-min video and an exercise booklet, and failed to reduce anxiety and depression in patients with cancer undergoing chemotherapy. We suggest that researchers implement weekly telephonic interviews and personal discussions with patients to increase their adherence rate, and also offer face-to-face instructions instead of videos when conducting a home-based exercise intervention study.

Regarding exercise intensity, because of the constraints of our research budget, we used both the heart rate and Borg\'s RPE that were measured by the patients themselves; however, accurate heart rate detection can be challenging for elderly people. We suggest that a future study with a larger budget use watch-like heart rate monitors to facilitate precise heart rate detection; this would reduce the measurement error when patients measure their own heart rate as well as the patient load for heart rate measurement, particularly on elderly patients. Moreover, in this study, three patients presented with postoperative dyspnoea; therefore, they could not endure moderate-intensity exercises during the first and second weeks of the walking-exercise programme, but adapted gradually after the second week. A previous study reported that light-intensity exercise has an antianxiety effect on breast cancer survivors ([@bib2]). Therefore, in future studies, moderate-intensity exercise should be modified to light-intensity exercise for patients with dyspnoea.

Regarding the effects of exercise on symptom severity, no substantial reduction was observed in the symptoms. This result is consistent with the results of two previous studies ([@bib7]; [@bib17]), wherein neither supervised exercise nor home-based exercise alleviated the cancer-related symptoms in patients with breast, colorectal and ovarian cancer. Although no significant difference was observed in the severity of symptoms between the two groups over time, the symptom scores of the walking-exercise group were marginally significantly lower than those of the usual-care group (1.50 *vs* 2.08 points, respectively, *P*=0.053) in the third month. A possible reason that symptoms were not relieved in this study is the floor effect, because the symptom scores of the participants averaged 2.0 points at baseline, indicating mild symptoms.

In the walking-exercise group, 14 (24.1%) patients dropped out, and 11 (19.0%) patients in the usual-care group dropped out. The patients who dropped out exhibited higher depression scores than did the non-dropout patients. This finding is similar to that of a study on patients enrolled in a cardiac rehabilitation programme; the depression status served as a predictor of the number of exercise sessions completed and the dropout rate ([@bib12]). We suggest that health-care providers conduct regular follow-ups of the depression status of patients, and encourage them to continue exercising when conducting an exercise programme.

The strengths of this trial include it being the first home-based walking-exercise, randomised controlled trial to focus on Taiwanese patients with lung cancer; the 97% recruitment rate; and the adoption of a feasible and flexible exercise programme. However, this study had several limitations. First, the registration was retrospective and may have created risk when changing the study design and analysis after data collation. To control the research quality, the progress of this study was reported annually to the Institutional Review Board of Taipei Veterans General Hospital (Taipei, Taiwan). Project aspects such as research design and intervention measures were not modified during the research period. Second, although lack of blinding is inevitable in this type of study, it may have induced a placebo effect on the patients and an observational bias among the researchers; therefore, the outcome assessors should be trained in standardised testing procedures to reduce bias. Third, three patients reported that they could not endure the moderate-intensity exercises during the first and second weeks; this negatively affected the intervention fidelity and possibly diluted the intervention effect. Other study limitations included the use of a single centre to recruit patients, the lack of blinding and the heterogeneity of this patient population. This home-based walking-exercise programme warrants adoption in lung cancer rehabilitation because of its connection with ADLs.

In summary, this paper is the first to document evidence regarding the feasibility and effectiveness of walking-exercise training programmes in patients with lung cancer. The study results suggest that home-based walking exercise can reduce anxiety and depression, and elucidate the critical role of exercise in the rehabilitation of patients with cancer. Health-care team members must comprehend and consider exercise as a supportive care intervention for lung cancer survivors.
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###### Demographic data and disease characteristics for all participants categorised based on the two groups (*n*=116)

  **Variables**                    **Walking-exercise group,** ***n*****=58**   **Usual-care group,** ***n*****=58**   ***P-*****value**[a](#t1-fn1){ref-type="fn"}
  -------------------------------- -------------------------------------------- -------------------------------------- ----------------------------------------------
  **Age (years)**                                                                                                      
  Mean (s.d.)                      64.76 (11.28)                                63.57 (10.54)                          0.559
  **Education (years)**                                                                                                
  Mean (s.d.)                      10.66 (4.73)                                 10.62 (4.66)                           0.969
  **Sex (*n*, %)**                                                                                                     
  Male                             26 (44.8)                                    28 (48.3)                              0.710
  Female                           32 (55.2)                                    30 (51.7)                               
  **Employment (*n*, %)**                                                                                              
  No                               42 (72.4)                                    34 (58.6)                              0.118
  Yes                              16 (27.6)                                    24 (41.4)                               
  **Marital status (*n*, %)**                                                                                          
  Married                          48 (82.8)                                    48 (82.8)                              1
  Not married/single               10 (17.2)                                    10 (17.2)                               
  **Cancer stage (*n*, %)**                                                                                            
  1                                34 (58.6)                                    41 (70.7)                              0.681
  2                                5 (8.6)                                      4 (6.9)                                 
  3                                6 (10.4)                                     5 (8.6)                                 
  4                                5 (8.6)                                      4 (6.9)                                 
  Unknown                          8 (13.8)                                     4 (6.9)                                 
  **Current treatment (*n*, %)**                                                                                       
  No treatment                     19 (32.8)                                    17 (29.3)                              0.889
  Operation                        30 (51.8)                                    33 (57.0)                               
  Chemotherapy                     1 (1.7)                                      0 (0.0)                                 
  Radiotherapy                     2 (3.4)                                      2 (3.4)                                 
  Target therapy                   4 (6.9)                                      5 (8.6)                                 
  Chemotherapy and radiotherapy    2 (3.4)                                      1 (1.7)                                 

The *P-*values are based on *χ*^2^ analyses for categorical variables and *t-*tests for continuous variables.

###### Intention-to-treat analysis: mean and s.d. values and outcome differences between both groups at baseline and at third and sixth months according to the general linear model

                                                **Baseline**   **Thirrd month**   **Sixth month**                                                                                     
  --------------------------------------------- -------------- ------------------ ----------------- ---- ------ ------ ---------------- --------- ---- ------ ------ ---------------- ---------
  **Anxiety**                                                                                                                                                                         
  Walking group                                 58             4.59               3.46              50   4.59   2.63        −0.63       0.379     44   3.55   3.34        −1.03       0.168
  Usual-care group[a](#t2-fn3){ref-type="fn"}   58             3.50               3.91              51   5.22   4.01    (−2.04; 0.78)             47   4.57   3.96     (−2.49;0.43)    
  **Depression**                                                                                                                                                                      
  Walking group                                 58             5.67               3.57              50   4.92   3.14        −2.45       0.001\*   44   4.41   3.79        −1.68       0.035\*
  Usual-care group[a](#t2-fn3){ref-type="fn"}   58             4.74               3.73              51   7.37   4.52    (−3.95; −0.95)            47   6.09   4.11    (−3.23; −0.12)   
  **Symptoms**                                                                                                                                                                        
  Walking group                                 58             1.93               1.45              50   1.50   1.27        −0.58       0.053     44   1.54   1.68        −0.21       0.512
  Usual-care group[a](#t2-fn3){ref-type="fn"}   58             2.04               1.48              51   2.08   1.65    (−1.18; 0.01)             47   1.74   1.55    (−0.82; 0.41)    

Abbreviation: CI=confidence interval.

\**P* \<0.05.

Usual-care group is reference group.

###### Results of the generalised linear model[a](#t3-fn3){ref-type="fn"} regarding the effects of walking exercise on anxiety, depression and cancer-related symptoms (*n*=116)

  **Variables**                 ***β***     **s.e.**   ***P*****-value**
  ----------------------------- ----------- ---------- -------------------
  **Anxiety**                                          
  Group (WG *vs* UG)            1.09        0.68       0.110
  Time                                                  
   Baseline                     Reference               
   Third month                  1.75        0.52       0.001\*
   Sixth month                  1.07        0.53       0.042\*
  Group × time                                          
   Group × baseline             Reference               
   Group × third month          −1.80       0.69       0.009\*
   Group × sixth month          −2.18       0.79       0.006\*
  **Depression**                                       
  Group (WG *vs* UG)            0.93        0.67       0.166
  Time                                                  
   Baseline                     Reference               
   Third month                  2.66        0.59       0.00001\*
   Sixth month                  1.44        0.58       0.013\*
  Group × time                                          
   Group × baseline             Reference               
   Group × third month          −3.31       0.83       0.00006\*
   Group × sixth month          −2.57       0.88       0.004\*
  **Cancer-related symptoms**                          
  Group (WG *vs* UG)            −0.11       0.27       0.679
  Time                                                  
   Baseline                     Reference               
   Third month                  −0.03       0.15       0.819
   Sixth month                  −0.38       0.18       0.039\*
  Group × time                                          
   Group × baseline             Reference               
   Group × third month          −0.43       0.22       0.050
   Group × sixth month          −0.03       0.30       0.910

Abbreviations: *β*=modelling coefficient; UG=usual-care group; WG=walking-exercise group.

\**P*\<0.05.

Using generalised estimation equations for repeated measurements and exchangeable correlation structure.

###### Effects of walking exercise on the Hospital Anxiety and Depression Scale (HADS) outcome variables according to the clinical cutoff point at baseline and at third and sixth months (general linear model)

                                                **Pretest,**[a](#t4-fn3){ref-type="fn"} **case number (%)**   **Third month, case number (%)**                           **Sixth month, case number (%)**                                                            
  --------------------------------------------- ------------------------------------------------------------- ---------------------------------- ----------- ----------- ---------------------------------- --------- ----------- ----------- ------ ------- ------- ---------
  Anxiety                                                                                                                                                                6.04                               0.014\*                           2.45   0.118   6.04    0.049\*
  Walking-exercise group                        13 (22.4)                                                     45 (77.6)                          9 (18.4)    40 (81.6)                                                5 (11.4)    39 (88.6)                           
  Usual-care group[a](#t4-fn3){ref-type="fn"}   8 (13.8)                                                      50 (86.2)                          17 (34.7)   32 (65.3)                                                8 (17.0)    39 (83.0)                           
  Depression                                                                                                                                                             10.26                              0.001\*                           1.28   0.257   10.74   0.005\*
  Walking-exercise group                        18 (31.0)                                                     40 (69.0)                          10 (20.4)   39 (79.6)                                                13 (29.5)   31 (70.5)                           
  Usual-care group[a](#t4-fn3){ref-type="fn"}   14 (24.1)                                                     44 (75.9)                          23(46.9)    26(53.1)                                                 16 (34.0)   31 (66.0)                           

Using generalised estimation equations for repeated measurements and (AR1) correlation structure.

\**P*\<0.05.

Reference group.
